Sodium Cromoglicate

色甘酸钠

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSodium Cromoglicate
Drug Alias NameCromolyn Sodium色甘酸药Sodyum Kromoglikat色甘酸二钠Sodium chromoglycate +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMast cells stabilizersGlial cells modulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Exercise-induced bronchoconstrictionSchizophrenia +[10] 
Global Approved IndicationsConjunctivitis, AllergicAsthma
Approved Indications in ChinaConjunctivitis, AllergicAsthma
Original Approved Country/TerritoryUnited States
Original Approved Date1973/09/01
Country/TerritoryBelgiumUnited StatesPortugal +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesLupin Atlantis Holdings SaStanley Medical Research InstituteLupin Ltd +[5] 
Inactive CompaniesShiraz University Of Medical SciencesUniversitaire Ziekenhuizen LeuvenTexas Tech University Health Sciences Center El Paso +[6] 
Active IndicationsSchizophreniaConjunctivitis, AllergicAsthma
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Exercise-induced bronchoconstrictionPruritus +[7] 

Other Information

ATC CodeA07EB01D11AH03R01AC01 +[5] 
Related LinksWikipediaDrugBankKEGG